基于临床和蛋白质基的综合模型用于pRCC的诊断和预后预测
Zeya Xu1, Linhui Zhang1,2, Jiacheng Lyu1
1Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute, Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200433, China.
这项研究开发了血蛋白质组模型,以准确诊断癌亚型和状细胞癌 (pRCC) 阶段. 这些模型为改善PRCC诊断和进展监测提供了非侵入性工具.
科学领域:
- 发现生物标志物的发现.
- 蛋白质组学是指蛋白质组学.
- 细胞癌研究 细胞癌研究
背景情况:
- 乳头性细胞癌 (pRCC) 是一种异质的非清晰细胞亚型,预后不佳.
- 由于其发病率较低,对于pRCC存在有限的研究和非侵入性生物标志物.
- pRCC通常被错误分类,突出了需要准确的诊断工具的需要.
更多相关视频
07:01Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
